Related Experiment Video
Updated: Apr 20, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
13.2K
[Human immunodeficiency virus-associated thrombotic microangiopathies]
L Gilardin1, S Malak, Y Schoindre
1Département d'hématologie, UPMC université Paris-06, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, AP-HP, 75012 Paris, France.
La Revue De Medecine Interne
|January 28, 2012
Summary
Human immunodeficiency virus (HIV) infection can cause two distinct thrombotic microangiopathies. Prompt diagnosis and treatment, including plasma exchange and antiretroviral therapy, improve outcomes for HIV-associated thrombotic thrombocytopenic purpura.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Context:
- Human immunodeficiency virus (HIV) infection is a known risk factor for thrombotic microangiopathy.
- HIV-associated thrombotic microangiopathies present distinct clinical and pathological features.
- Understanding these differences is crucial for effective patient management.
Purpose:
- To differentiate between the two main entities of HIV-associated thrombotic microangiopathies.
- To outline current management strategies and their impact on prognosis.
- To highlight areas for future research in HIV-related thrombotic microangiopathy.
Summary:
- HIV-associated thrombotic microangiopathies include thrombotic thrombocytopenic purpura (TTP) and a progressive form.
- HIV-TTP, seen in moderately immunocompromised patients, involves severe ADAMTS13 deficiency and responds well to plasma exchange and antiretroviral therapy.
- The progressive form, in severely immunocompromised patients, has a poorer prognosis with less effective treatments.
Impact:
- This research clarifies diagnostic and therapeutic approaches for HIV-associated thrombotic microangiopathies.
- It emphasizes the importance of early intervention and tailored treatment strategies.
- Future studies may focus on immunomodulatory drugs like rituximab and identifying risk factors.
More Related Videos
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:25Immunodeficiency Diseases
3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
3.7K
01:26Sexually Transmitted Infections
1.8K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.8K
01:30Venous Thrombosis I: Introduction
780
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
780
01:29Venous Thrombosis III: Interprofessional Care
477
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
477
01:26Transient Ischemic Attack l: Introduction
2
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
2